Zelnorm

Zelnorm, a Novartis drug for painful bowel symptoms, was pulled from the market because of another meta-analysis that showed an increased risk of heart attacks.

A Consumer's Guide To Medical Jargon 2010

On Thursday, Novartis said it has reached a tentative agreement to settle 124 lawsuits brought by consumers who claim their use of the gastrointestinal drug Zelnorm caused heart-related injuries.

Healthy Drug Sales Boost Novartis Results 2010

The company didn't dis close how much it is paying in the Zelnorm settlement, which was reached in May.

Healthy Drug Sales Boost Novartis Results 2010

Zelnorm, a Novartis drug for painful bowel symptoms, was pulled from the market because of another meta-analysis that showed an increased risk of heart attacks.

A Consumer's Guide To Medical Jargon Robert Langretth 2010

During a third campaign -- for Novartis AG's Zelnorm, a since-withdrawn treatment for irritable-bowel syndrome -- usage in English-speaking Canada went up briefly over Quebec but soon settled back.

U.S. Drug Ads Questioned 2008

Food and Drug Administration, and had to remove a drug for irritable bowel syndrome, Zelnorm, from the market due to safety concerns.

Novartis Picks Up Eye-Care Unit 2008

And coming up, more details on the widely-used drug Zelnorm.

CNN Transcript Mar 30, 2007 2007

Earlier this year, it also was forced to withdraw from the U.S. and Swiss markets its drug for irritable-bowel syndrome, Zelnorm, after safety concerns.

Novartis Plans Restructuring 2007

Sales of irritable-bowel-syndrome drug Zelnorm have plummeted 80% this year after the company withdrew the drug from the market in March at the request of the FDA, which was concerned about a possible link to angina, heart attacks and strokes.

Novartis Shakes Ranks as Earnings Flag 2007

The FDA says there have been rare clinical links to heart attack, stroke, or angina, or chest pain, in patients who take Zelnorm.

CNN Transcript Mar 30, 2007 2007